Treace Medical Concepts, Inc. (TMCI)

Treace Medical Concepts Stock Forecast

Stock Price Forecast

The 5 analysts that cover Treace Medical Concepts stock have a consensus rating of "Hold" and an average price target of $4.77, which forecasts a 226.71% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $7.00.

Price Target: $4.77 (+226.71%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$3.00	$4.77	$5.00	$7.00
Change	+105.48%	+226.71%	+242.47%	+379.45%

Analyst Ratings

The average analyst rating for Treace Medical Concepts stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	1	1	1	0	0	1
Buy	0	0	0	0	0	0
Hold	4	4	4	4	4	4
Sell	0	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	5	6	6	5	5	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ben Haynor Lake Street	Lake Street	Strong Buy Maintains $7.5 → $7	Strong Buy	Maintains	$7.5 → $7	+379.45%	Mar 2, 2026
Rick Wise Stifel	Stifel	Hold Maintains $5 → $3	Hold	Maintains	$5 → $3	+105.48%	Jan 7, 2026
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $4 → $3	Hold	Maintains	$4 → $3	+105.48%	Dec 18, 2025
Richard Newitter Truist Securities	Truist Securities	Hold Reiterates $7 → $4	Hold	Reiterates	$7 → $4	+173.97%	Nov 10, 2025
Danielle Antalffy UBS	UBS	Hold Maintains $6.5 → $5.85	Hold	Maintains	$6.5 → $5.85	+300.68%	Nov 7, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

210.80M

Decreased by -0.89%

from 212.69M

Revenue Next Year

226.92M

Increased by 7.65%

from 210.80M

EPS This Year

-0.87

from -0.93

EPS Next Year

-0.80

from -0.87

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	94.42M	141.84M	187.12M	209.36M	212.69M	210.80M	226.92M
Revenue Growth	64.59%	50.22%	31.92%	11.89%	1.59%	-0.89%	7.65%
EPS	-0.43	-0.77	-0.81	-0.90	-0.93	-0.87	-0.80
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	224.5M	254.5M
Avg	210.8M	226.9M
Low	199.4M	209.4M

Revenue Growth

Revenue Growth	2026	2027	2028
High	5.5%	20.7%
Avg	-0.9%	7.6%
Low	-6.2%	-0.7%

EPS Forecast

EPS	2026	2027	2028
High	-0.71	-0.65
Avg	-0.87	-0.80
Low	-0.91	-0.94

EPS Growth

EPS Growth	2026	2027	2028
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.